23 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
a 3-point improvement in mADL11
14 Essential3: An innovative Phase 3 program that optimizes all aspects of study conduct Single Recruiting Expert
8-K
EX-3.1
hx4pxx
7 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
424B4
a4tb 87dvupulo
14 May 21
Prospectus supplement with pricing info
4:34pm
DEF 14A
srp u27uclykuy
29 Apr 21
Definitive proxy
4:04pm
10-K
5eq5of
17 Mar 21
Annual report
8:33am
8-K
EX-3.2
y75jmtjit
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B4
22h9onjdlx36cdw
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
EX-10.16
ildcl
25 Sep 20
IPO registration
5:19pm
S-1
EX-3.4
85mvfd4c9xg2mtmty61c
25 Sep 20
IPO registration
5:19pm
S-1
EX-10.15
2bns0
25 Sep 20
IPO registration
5:19pm
S-1
5d2bhp3c7i60hqq0x
25 Sep 20
IPO registration
5:19pm
DRS/A
m56 0cnneln
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
5tk25qvv 9h1m7
28 Aug 20
Draft registration statement (amended)
12:00am